X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs VENUS REMEDIES - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS VENUS REMEDIES J.B.CHEMICALS/
VENUS REMEDIES
 
P/E (TTM) x 13.3 -9.0 - View Chart
P/BV x 2.1 0.1 1,502.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   VENUS REMEDIES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
VENUS REMEDIES
Mar-17
J.B.CHEMICALS/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs318143 222.8%   
Low Rs20065 306.9%   
Sales per share (Unadj.) Rs148.0324.2 45.6%  
Earnings per share (Unadj.) Rs19.16.4 297.7%  
Cash flow per share (Unadj.) Rs23.940.6 59.0%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.9366.0 35.2%  
Shares outstanding (eoy) m84.8212.34 687.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.3 545.7%   
Avg P/E ratio x13.616.2 83.7%  
P/CF ratio (eoy) x10.82.6 422.1%  
Price / Book Value ratio x2.00.3 706.9%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9511,282 1,712.1%   
No. of employees `0002.70.9 302.8%   
Total wages/salary Rs m1,841251 733.5%   
Avg. sales/employee Rs Th4,590.94,430.1 103.6%   
Avg. wages/employee Rs Th673.4278.0 242.3%   
Avg. net profit/employee Rs Th592.187.6 675.9%   
INCOME DATA
Net Sales Rs m12,5514,000 313.8%  
Other income Rs m54223 2,385.9%   
Total revenues Rs m13,0934,023 325.4%   
Gross profit Rs m2,055785 261.8%  
Depreciation Rs m412422 97.8%   
Interest Rs m96344 27.8%   
Profit before tax Rs m2,08842 4,960.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469-37 -1,267.8%   
Profit after tax Rs m1,61979 2,046.4%  
Gross profit margin %16.419.6 83.5%  
Effective tax rate %22.5-87.9 -25.6%   
Net profit margin %12.92.0 652.2%  
BALANCE SHEET DATA
Current assets Rs m7,7782,606 298.4%   
Current liabilities Rs m4,3581,980 220.1%   
Net working cap to sales %27.215.6 174.1%  
Current ratio x1.81.3 135.6%  
Inventory Days Days55128 42.6%  
Debtors Days Days8043 185.5%  
Net fixed assets Rs m5,7135,353 106.7%   
Share capital Rs m170123 137.4%   
"Free" reserves Rs m10,5474,393 240.1%   
Net worth Rs m10,9374,516 242.2%   
Long term debt Rs m01,618 0.0%   
Total assets Rs m15,5748,291 187.8%  
Interest coverage x22.81.1 2,033.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.5 167.0%   
Return on assets %11.05.1 215.9%  
Return on equity %14.81.8 845.0%  
Return on capital %20.06.3 317.4%  
Exports to sales %48.70-   
Imports to sales %7.118.4 38.5%   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889736 120.7%   
Fx inflow Rs m6,1690-   
Fx outflow Rs m1,285736 174.5%   
Net fx Rs m4,884-736 -663.3%   
CASH FLOW
From Operations Rs m1,397997 140.1%  
From Investments Rs m-320-461 69.4%  
From Financial Activity Rs m-1,196-571 209.4%  
Net Cashflow Rs m-102-35 291.5%  

Share Holding

Indian Promoters % 55.4 32.9 168.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.2 1,883.3%  
FIIs % 3.9 0.6 672.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 66.4 55.7%  
Shareholders   30,437 20,121 151.3%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   UNICHEM LAB  SUN PHARMA  PIRAMAL ENTERPRISES  WOCKHARDT LTD.  AUROBINDO PHARMA  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

VENUS REMEDIES Announces Quarterly Results (4QFY18); Net Profit Down 307.2%

Jun 12, 2018 | Updated on Jun 12, 2018

For the quarter ended March 2018, VENUS REMEDIES has posted a net profit of Rs 94 m (down 307.2% YoY). Sales on the other hand came in at Rs 932 m (up 16.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 21, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - SANOFI INDIA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS